<DOC>
	<DOCNO>NCT00514111</DOCNO>
	<brief_summary>The aim study evaluate sustain virologic response ( RVS ) HVC patient treat pegylated-interferon conventional-interferon ribavirin , investigate associate factor RVS , mean retrospective analysis .</brief_summary>
	<brief_title>Factors Associated Success Hepatitis C Therapy</brief_title>
	<detailed_description>Chronic hepatitis C virus ( HVC ) major public-health problem since present long phase clinical latency make early diagnosis difficult result development large number case complication cirrhosis , hepatic insufficiency hepatocarcinoma . In Brazil , estimate three million estimate case 52 thousand report . The aim study evaluate sustain virologic response ( RVS ) HVC patient treat pegylated-interferon conventional-interferon ribavirin , investigate associate factor RVS , mean retrospective analysis .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>HVC patient receive specific treatment pegylatedinterferon conventionalinterferon , ribavirin No HVC infection treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>